Daniel S. Harrison, MD
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Neurology




Neurologic disease is even more frightening and life-altering for patients and their families than it is fascinating to neurologists. In residency, I was particularly attracted to treating the most acute presentations of neurologic disease, ultimately leading me towards a career in critical care. The passion for clinical excellence that initially drew me to medicine has been solidified in my training and will be a cornerstone of my career as an academic neurointensivist.

Dedicated teaching of neurology trainees is critical to future of excellent clinical care. I lecture and lead journal clubs for trainees and APPs locally and nationally. I have instructed, directed, and created simulation courses for neurology trainees, APPs, and nurses. I especially enjoy mentoring residents and APPs undertaking original education research projects.

I am a medical education researcher with interests in neurologic education for APPs and medical simulation. My research describing neurologic education in PA programs was recognized as an editorial board top pick in Neurology Today. I lead national collaborations of physician and APP leaders in neurologic education who aim to describe onboarding practices for neurology APPs and define consensus EPAs for neurocritical care APPs. In addition to original research, I have served as neurology section editor of local reference materials, including the MGH Housestaff Manual, and my first authored textbook chapter is in press.

I was a neurology chief resident at MGB during the height of the COVID pandemic, playing an active role in crisis management and ensuring the wellness of our resident community, which affirmed my interest in pursuing GME leadership after completing my training. I am passionate about caring for patients, understanding current and innovating new educational infrastructure, using this knowledge to optimize teaching, and leading in the fields of neurology and neurocritical care.

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Harrison DS. Hickam's Dictum: A Case of Intracerebral Hemorrhage with Multiple Contributing Risk Factors. Neurocrit Care. 2024 Feb; 40(1):367-370. PMID: 38167963
     
  2. Khayat-Khoei M, Bhattacharyya S, Katz J, Harrison D, Tauhid S, Bruso P, Houtchens MK, Edwards KR, Bakshi R. COVID-19 mRNA vaccination leading to CNS inflammation: a case series. J Neurol. 2022 Mar; 269(3):1093-1106. PMID: 34480607; DOI: 10.1007/s00415-021-10780-7;
     
  3. Harrison D, Mehta P, van Es MA, Stommel E, Drory VE, Nefussy B, van den Berg LH, Crayle J, Bedlack R. "ALS reversals": demographics, disease characteristics, treatments, and co-morbidities. Amyotroph Lateral Scler Frontotemporal Degener. 2018 Nov; 19(7-8):495-499. PMID: 29607695; DOI: 10.1080/21678421.2018.1457059;
     
  4. Li Y, North RY, Rhines LD, Tatsui CE, Rao G, Edwards DD, Cassidy RM, Harrison DS, Johansson CA, Zhang H, Dougherty PM. DRG Voltage-Gated Sodium Channel 1.7 Is Upregulated in Paclitaxel-Induced Neuropathy in Rats and in Humans with Neuropathic Pain. J Neurosci. 2018 Jan 31; 38(5):1124-1136. PMID: 29255002; DOI: 10.1523/JNEUROSCI.0899-17.2017;
     
  5. Li Y, Tatsui CE, Rhines LD, North RY, Harrison DS, Cassidy RM, Johansson CA, Kosturakis AK, Edwards DD, Zhang H, Dougherty PM. Dorsal root ganglion neurons become hyperexcitable and increase expression of voltage-gated T-type calcium channels (Cav3.2) in paclitaxel-induced peripheral neuropathy. Pain. 2017 Mar; 158(3):417-429. PMID: 27902567; DOI: 10.1097/j.pain.0000000000000774;
     
  6. Li Y, Adamek P, Zhang H, Tatsui CE, Rhines LD, Mrozkova P, Li Q, Kosturakis AK, Cassidy RM, Harrison DS, Cata JP, Sapire K, Zhang H, Kennamer-Chapman RM, Jawad AB, Ghetti A, Yan J, Palecek J, Dougherty PM. The Cancer Chemotherapeutic Paclitaxel Increases Human and Rodent Sensory Neuron Responses to TRPV1 by Activation of TLR4. J Neurosci. 2015 Sep 30; 35(39):13487-500. PMID: 26424893; DOI: 10.1523/JNEUROSCI.1956-15.2015;
     
  7. Li Y, Zhang H, Kosturakis AK, Cassidy RM, Zhang H, Kennamer-Chapman RM, Jawad AB, Colomand CM, Harrison DS, Dougherty PM. MAPK signaling downstream to TLR4 contributes to paclitaxel-induced peripheral neuropathy. Brain Behav Immun. 2015 Oct; 49:255-66. PMID: 26065826; DOI: 10.1016/j.bbi.2015.06.003;
     
  8. Wood ET, Ronen I, Techawiboonwong A, Jones CK, Barker PB, Calabresi P, Harrison D, Reich DS. Investigating axonal damage in multiple sclerosis by diffusion tensor spectroscopy. J Neurosci. 2012 May 09; 32(19):6665-9. PMID: 22573688
     

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 8 publications over 6 distinct years, with a maximum of 2 publications in 2015 and 2017

YearPublications
20121
20152
20172
20181
20211
20241

Contact for Mentoring:

Harrison's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Similar People
_
Same Department